Green Cross Holdings Corporation (005250.KS)
KRW 13380.0
(3.72%)
KRW 13380.0
(3.72%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 620.02 Billion KRW | -6.64% |
| 2022 | 627.17 Billion KRW | 15.67% |
| 2021 | 542.21 Billion KRW | 17.99% |
| 2020 | 459.52 Billion KRW | 15.06% |
| 2019 | 399.36 Billion KRW | 11.83% |
| 2018 | 357.13 Billion KRW | 18.92% |
| 2017 | 300.31 Billion KRW | 2.32% |
| 2016 | 293.51 Billion KRW | 12.03% |
| 2015 | 261.99 Billion KRW | 17.95% |
| 2014 | 222.12 Billion KRW | 8.82% |
| 2013 | 204.13 Billion KRW | 9.91% |
| 2012 | 185.71 Billion KRW | 12.46% |
| 2011 | 165.13 Billion KRW | -2.53% |
| 2010 | 169.42 Billion KRW | 12.64% |
| 2009 | 150.41 Billion KRW | 7.62% |
| 2008 | 139.76 Billion KRW | 4.21% |
| 2007 | 134.11 Billion KRW | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 145.91 Billion KRW | 10.86% |
| 2024 Q1 | 142.67 Billion KRW | -3.82% |
| 2023 Q1 | 151.09 Billion KRW | -18.73% |
| 2023 Q3 | -150.22 Billion KRW | 6.46% |
| 2023 Q2 | -160.59 Billion KRW | -206.29% |
| 2023 Q4 | 148.34 Billion KRW | 198.75% |
| 2023 FY | 585.52 Billion KRW | -6.64% |
| 2022 Q2 | 162.27 Billion KRW | 226.51% |
| 2022 Q3 | 150.72 Billion KRW | -7.11% |
| 2022 Q4 | 185.91 Billion KRW | 23.34% |
| 2022 Q1 | -128.26 Billion KRW | -175.92% |
| 2022 FY | 627.17 Billion KRW | 15.67% |
| 2021 Q1 | 107.54 Billion KRW | -30.39% |
| 2021 Q4 | 168.94 Billion KRW | 25.29% |
| 2021 FY | 542.21 Billion KRW | 17.99% |
| 2021 Q3 | 134.84 Billion KRW | 3.03% |
| 2021 Q2 | 130.87 Billion KRW | 21.7% |
| 2020 Q2 | 114.09 Billion KRW | 14.61% |
| 2020 Q1 | 99.54 Billion KRW | -16.43% |
| 2020 Q3 | 108.97 Billion KRW | -4.48% |
| 2020 FY | 459.52 Billion KRW | 15.06% |
| 2020 Q4 | 154.48 Billion KRW | 41.76% |
| 2019 Q2 | 98.2 Billion KRW | 13.43% |
| 2019 Q4 | 119.12 Billion KRW | 24.79% |
| 2019 FY | 399.36 Billion KRW | 11.83% |
| 2019 Q3 | 95.46 Billion KRW | -2.8% |
| 2019 Q1 | 86.57 Billion KRW | -18.19% |
| 2018 Q2 | 84.8 Billion KRW | 8.78% |
| 2018 Q3 | 88.54 Billion KRW | 4.41% |
| 2018 FY | 357.13 Billion KRW | 18.92% |
| 2018 Q1 | 77.96 Billion KRW | -7.93% |
| 2018 Q4 | 105.82 Billion KRW | 19.52% |
| 2017 FY | 300.31 Billion KRW | 2.32% |
| 2017 Q4 | 84.67 Billion KRW | 9.32% |
| 2017 Q3 | 77.45 Billion KRW | 8.94% |
| 2017 Q2 | 71.1 Billion KRW | 6.0% |
| 2017 Q1 | 67.07 Billion KRW | -17.76% |
| 2016 Q1 | 63.79 Billion KRW | -23.23% |
| 2016 Q2 | 74.45 Billion KRW | 16.71% |
| 2016 Q3 | 73.69 Billion KRW | -1.01% |
| 2016 Q4 | 81.56 Billion KRW | 10.67% |
| 2016 FY | 293.51 Billion KRW | 12.03% |
| 2015 FY | 261.99 Billion KRW | 17.95% |
| 2015 Q4 | 83.09 Billion KRW | 36.21% |
| 2015 Q3 | 61 Billion KRW | -1.1% |
| 2015 Q2 | 61.69 Billion KRW | 9.78% |
| 2015 Q1 | 56.19 Billion KRW | -14.2% |
| 2014 FY | 222.12 Billion KRW | 8.82% |
| 2014 Q3 | 52.54 Billion KRW | 2.18% |
| 2014 Q2 | 51.42 Billion KRW | -2.33% |
| 2014 Q1 | 52.65 Billion KRW | -10.28% |
| 2014 Q4 | 65.49 Billion KRW | 24.64% |
| 2013 Q4 | 58.68 Billion KRW | 14.36% |
| 2013 FY | 204.13 Billion KRW | 9.91% |
| 2013 Q1 | 47.05 Billion KRW | -19.74% |
| 2013 Q2 | 47.07 Billion KRW | 0.06% |
| 2013 Q3 | 51.31 Billion KRW | 9.0% |
| 2012 Q3 | 44.18 Billion KRW | 2.69% |
| 2012 Q2 | 43.03 Billion KRW | 7.84% |
| 2012 Q1 | 39.9 Billion KRW | -13.99% |
| 2012 FY | 185.71 Billion KRW | 12.46% |
| 2012 Q4 | 58.62 Billion KRW | 32.67% |
| 2011 Q1 | 31.02 Billion KRW | 0.0% |
| 2011 Q3 | 41.97 Billion KRW | -2.94% |
| 2011 Q4 | 46.39 Billion KRW | 10.54% |
| 2011 Q2 | 43.24 Billion KRW | 39.36% |
| 2011 FY | 165.13 Billion KRW | -2.53% |
| 2010 Q2 | 2.56 Billion KRW | -16.58% |
| 2010 Q3 | 3.64 Billion KRW | 41.97% |
| 2010 FY | 169.42 Billion KRW | 12.64% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q1 | 3.07 Billion KRW | 0.0% |
| 2009 Q3 | 3.01 Billion KRW | -3.54% |
| 2009 Q2 | 3.12 Billion KRW | 35.58% |
| 2009 Q1 | 2.3 Billion KRW | 0.0% |
| 2009 FY | 150.41 Billion KRW | 7.62% |
| 2009 Q4 | - KRW | -100.0% |
| 2008 Q3 | 2.11 Billion KRW | -29.91% |
| 2008 Q2 | 3.01 Billion KRW | 85.61% |
| 2008 Q1 | 1.62 Billion KRW | 0.0% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 FY | 139.76 Billion KRW | 4.21% |
| 2007 Q1 | 2.12 Billion KRW | 0.0% |
| 2007 FY | 134.11 Billion KRW | 0.0% |
| 2007 Q4 | - KRW | -100.0% |
| 2007 Q2 | 3.74 Billion KRW | 76.36% |
| 2007 Q3 | 2.2 Billion KRW | -41.05% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ORIENT BIO Inc. | 10.23 Billion KRW | -5960.601% |
| Green Cross Holdings Corporation | 424.43 Billion KRW | -46.082% |
| Pharmicell Co., Ltd. | 14 Billion KRW | -4327.394% |
| Green Cross Corporation | 424.43 Billion KRW | -46.082% |
| GeneOne Life Science, Inc. | 40.6 Billion KRW | -1426.814% |
| Celltrion, Inc. | 359.46 Billion KRW | -72.483% |
| Samsung Biologics Co.,Ltd. | 638.51 Billion KRW | 2.897% |
| SK bioscience Co.,Ltd. | 154.23 Billion KRW | -302.009% |
| SK Biopharmaceuticals Co., Ltd. | 358.33 Billion KRW | -73.03% |
| Prestige BioPharma Limited | 63.47 Billion KRW | -876.841% |